Publication: Randomized, Double-Blind, Placebo-Controlled Crossover Trial of Once Daily Empagliflozin 25 mg for the Treatment of Postprandial Hypoglycemia After Roux-en-Y Gastric Bypass
Randomized, Double-Blind, Placebo-Controlled Crossover Trial of Once Daily Empagliflozin 25 mg for the Treatment of Postprandial Hypoglycemia After Roux-en-Y Gastric Bypass
Date
Date
Date
Citations
Ferreira, A., Schönenberger, K. A., Potoczna, N., Vogt, A., Gerber, P. A., Zehetner, J., Giachino, D., Nett, P., Gawinecka, J., Cossu, L., Fuster, D. G., Dalla Man, C., Facchinetti, A., Melmer, A., Nakas, C. T., Hepprich, M., Donath, M. Y., Herzig, D., & Bally, L. (2023). Randomized, Double-Blind, Placebo-Controlled Crossover Trial of Once Daily Empagliflozin 25 mg for the Treatment of Postprandial Hypoglycemia After Roux-en-Y Gastric Bypass. Diabetes Technology & Therapeutics, 25(7), 467–475. https://doi.org/10.1089/dia.2023.0036
Abstract
Abstract
Abstract
Aims: To investigate the effect of empagliflozin on glucose dynamics in individuals suffering from postbariatric hypoglycemia (PBH) after Roux-en-Y gastric bypass (RYGB).
Methods: Twenty-two adults with PBH after RYGB were randomized to empagliflozin 25 mg or placebo once daily over 20 days in a randomized, double-blind, placebo-controlled, crossover trial. The primary efficacy outcome was the amplitude of plasma glucose excursion (peak to nadir) during a mixed-meal tolerance test (MMTT). Outcomes of the outpatient period were assess
Additional indexing
Creators (Authors)
Volume
Volume
Volume
Number
Number
Number
Page range/Item number
Page range/Item number
Page range/Item number
Page end
Page end
Page end
Item Type
Item Type
Item Type
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Keywords
Language
Language
Language
Publication date
Publication date
Publication date
Date available
Date available
Date available
ISSN or e-ISSN
ISSN or e-ISSN
ISSN or e-ISSN
Additional Information
Additional Information
Additional Information
OA Status
OA Status
OA Status
Publisher DOI
Citations
Ferreira, A., Schönenberger, K. A., Potoczna, N., Vogt, A., Gerber, P. A., Zehetner, J., Giachino, D., Nett, P., Gawinecka, J., Cossu, L., Fuster, D. G., Dalla Man, C., Facchinetti, A., Melmer, A., Nakas, C. T., Hepprich, M., Donath, M. Y., Herzig, D., & Bally, L. (2023). Randomized, Double-Blind, Placebo-Controlled Crossover Trial of Once Daily Empagliflozin 25 mg for the Treatment of Postprandial Hypoglycemia After Roux-en-Y Gastric Bypass. Diabetes Technology & Therapeutics, 25(7), 467–475. https://doi.org/10.1089/dia.2023.0036